Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of two standard initial antiretroviral regimens on lipid metabolism
2007-002698-29Phase 4Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in human immunodeficiency virus infection (HIV) comparing lopinavir/ritonavir + tenofovir/emtricitabine with efavirenz + tenofovir/emtricitabine (2 arms). Primary endpoints: Change in total cholesterol, Change in HDL cholesterol and 1 more. Started Jul 2007; status: active.
02
Drugs
lopinavir + ritonavirefavirenztenofoviremtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-002698-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002698-29.